DD202290A5 - Verfahren zur herstellung von indolderivaten - Google Patents

Verfahren zur herstellung von indolderivaten Download PDF

Info

Publication number
DD202290A5
DD202290A5 DD81235742A DD23574281A DD202290A5 DD 202290 A5 DD202290 A5 DD 202290A5 DD 81235742 A DD81235742 A DD 81235742A DD 23574281 A DD23574281 A DD 23574281A DD 202290 A5 DD202290 A5 DD 202290A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
alkyl
deep
converting
Prior art date
Application number
DD81235742A
Other languages
German (de)
English (en)
Inventor
Peter E Cross
Roger P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD202290A5 publication Critical patent/DD202290A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DD81235742A 1980-12-15 1981-12-14 Verfahren zur herstellung von indolderivaten DD202290A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8040081 1980-12-15

Publications (1)

Publication Number Publication Date
DD202290A5 true DD202290A5 (de) 1983-09-07

Family

ID=10517993

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81235742A DD202290A5 (de) 1980-12-15 1981-12-14 Verfahren zur herstellung von indolderivaten

Country Status (22)

Country Link
US (1) US4363912A (enExample)
EP (1) EP0054417B1 (enExample)
JP (1) JPS57181082A (enExample)
KR (1) KR830007552A (enExample)
AR (1) AR229110A1 (enExample)
AU (1) AU525296B2 (enExample)
CA (1) CA1143737A (enExample)
CS (1) CS228527B2 (enExample)
DD (1) DD202290A5 (enExample)
DE (1) DE3167879D1 (enExample)
DK (1) DK552581A (enExample)
ES (1) ES8308872A1 (enExample)
FI (1) FI814003A7 (enExample)
GR (1) GR76355B (enExample)
IE (1) IE51949B1 (enExample)
IL (1) IL64534A0 (enExample)
NO (1) NO814264L (enExample)
PH (1) PH17576A (enExample)
PL (1) PL133634B1 (enExample)
PT (1) PT74123B (enExample)
YU (1) YU293481A (enExample)
ZA (1) ZA818665B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
GB8609175D0 (en) * 1986-04-15 1986-05-21 Ici America Inc Heterocyclic carboxamides
ATE269861T1 (de) * 1998-03-31 2004-07-15 Inst For Pharm Discovery Inc Substituierte indolalkansäure
TNSN99224A1 (fr) * 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
WO2001051489A2 (en) * 2000-01-14 2001-07-19 The Institutes For Pharmaceutical Discovery, Llc Methods for lowering uric acid levels
ES2268480T3 (es) * 2002-12-10 2007-03-16 Wyeth Derivados del acido 3-alquilo- y 3-arilalquilo-1h-indol-1-il-acetico sustituidos como inhibidores del inhibidor del activador del plasminogeno-1 (pai-1).
GB0324763D0 (en) * 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
EP2046740B1 (en) 2006-07-22 2012-05-23 Oxagen Limited Compounds having crth2 antagonist activity
KR20100067677A (ko) * 2007-09-24 2010-06-21 알러간, 인코포레이티드 스핑고신-1-포스페이트 (ｓｐ1) 생물학적 활성을 갖는 아릴 또는 헤테로아릴 기를 함유하는 인돌 화합물
AU2009204700B2 (en) * 2008-01-18 2013-07-04 Atopix Therapeutics Limited Compounds having CRTH2 antagonist activity
US7750027B2 (en) * 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
JP2011509991A (ja) * 2008-01-22 2011-03-31 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
WO2009093026A1 (en) 2008-01-22 2009-07-30 Oxagen Limited Compounds having crth2 antagonist activity
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5173M (enExample) * 1966-02-11 1967-06-19
FR7337M (enExample) * 1968-01-11 1969-10-13
GB2045244B (en) 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives

Also Published As

Publication number Publication date
CA1143737A (en) 1983-03-29
DK552581A (da) 1982-06-16
PT74123A (en) 1982-01-01
AR229110A1 (es) 1983-06-15
JPS57181082A (en) 1982-11-08
FI814003L (fi) 1982-06-16
IL64534A0 (en) 1982-03-31
NO814264L (no) 1982-06-16
ZA818665B (en) 1982-10-27
PH17576A (en) 1984-10-01
FI814003A7 (fi) 1982-06-16
ES507960A0 (es) 1983-10-01
AU525296B2 (en) 1982-10-28
CS228527B2 (en) 1984-05-14
PL133634B1 (en) 1985-06-29
EP0054417A1 (en) 1982-06-23
IE51949B1 (en) 1987-04-29
EP0054417B1 (en) 1984-12-19
US4363912A (en) 1982-12-14
PL234253A1 (en) 1983-05-23
DE3167879D1 (en) 1985-01-31
AU7848881A (en) 1982-06-24
YU293481A (en) 1984-10-31
GR76355B (enExample) 1984-08-06
KR830007552A (ko) 1983-10-21
PT74123B (en) 1983-12-19
ES8308872A1 (es) 1983-10-01
IE812928L (en) 1982-06-15

Similar Documents

Publication Publication Date Title
DD202290A5 (de) Verfahren zur herstellung von indolderivaten
DE3008632C2 (enExample)
DE69132961T2 (de) Styrylsubstituierte heteroarylverbindungen, welche egf-rezeptor-tyrosinkinase inhibieren
CH644597A5 (de) Imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3001762A1 (de) Imidazol-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
EP1198453B9 (de) N-(indolcarbonyl-)piperazinderivate als 5-ht2a-rezeptor liganden
DD215546A5 (de) Verfahren zur herstellung bicyclischer thromboxansynthetase-inhibitoren
EP0268148A1 (de) Tetrahydronaphthalinderivate und diese enthaltende Arzneimittel
EP0778271A2 (de) Aminoalkyl-substituierte benzo-heterocyclische Verbindungen
DE69013959T2 (de) Aminobenzolsulfonsäurederivate.
DD218890A5 (de) Verfahren zur herstellung von n-(omega-(1h-imidazol-1-yl)-alkyl)-arylamiden
DE3530046C2 (de) Äthylendiaminmonoamid-Derivate
DD202714A5 (de) Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate
DE3032137A1 (de) 6-pyridazinone, deren herstellung und deren verwendung als kardiotonika
DE2112349A1 (de) Di- und tri-substituierte Imidazole
EP0007399B1 (de) Indolalkylamine, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
DE2434951B2 (de) In 3-stellung basisch substituierte diphenylhydantoine
DD149511A5 (de) Verfahren zur herstellung von 9-aminoalkylfluorenen
DE2932967A1 (de) Imidazol-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
DE69214113T2 (de) Neue Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3306146A1 (de) Pyridin-derivate und ihre verwendung als arzneimittel
EP0094080B1 (de) Pyrido(2,1-b)chinazolinderivate
DE2147882A1 (de) Triazole und tnazolhaltige Arznei mittel
EP1228041A2 (de) Indolderivate und deren verwendung als 5ht2a liganden
EP0194579B1 (de) Neue 3-Pyridylmethylnaphthylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel